Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

60 Degrees’ Arakoda Gets US FDA Panel Nod For Malaria Prophylaxis

Jul 27 2018

• By Sue Sutter

FDA Advisory Committee Feature image

Related Content

Tafenoquine Redux: 60 Degrees Pharma’s Malaria Drug Gets Its Turn At US FDA Panel

Jul 24 2018

GSK Moves Closer To Priority Review Voucher As US Panel Backs Malaria Drug Tafenoquine

Jul 13 2018

GSK Wins First-Ever Voucher Race With Anti-Malarial Approval

Jul 23 2018

Related Companies

GSK plc

Additional Topics

United States Advisory Committees Drug Review Regulation Infectious Diseases BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window